Jesse Cheng is a pharmacist who is specialized in Critical Care in Abington, Pennsylvania. Patients can reach him at 1200 Old York Rd, Abington or contact him on 215-430-3848. Active license number of Jesse Cheng is RPI012278 for Critical Care in Pennsylvania. Jesse Cheng is a licensed pharmacist who has demonstrated specialized knowledge and skill in the delivery of patient care services by pharmacists, as integral members of interprofessional teams, working to ensure the safe and effective use of medications in critically ill patients.
Complete Profile:
Jesse Cheng speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Jesse Cheng
Specialization:
Critical Care
Credentials:
PHARMD
Gender:
Male
Location:
1200 Old York Rd, Abington, Pennsylvania, 19001-3720
Phone:
215-430-3848
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Jesse Cheng are as mentioned below.
NPI Number:
1619708047
NPI Enumeration Date:
08 Aug, 2024
NPI Last Update On:
08 Aug, 2024
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jesse Cheng are as mentioned below.
Specialization
License Number
State
Status
Critical Care
RPI012278
Pennsylvania
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1200 Old York Rd, Abington, Pennsylvania
Zip:
19001-3720
Phone Number:
--
Fax Number:
--
Patients can reach Jesse Cheng at 1200 Old York Rd, Abington, Pennsylvania or can call on phone at 215-430-3848.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.